Navigation Links
WWMR, Inc. Announces Launch of New Pain Clinic Monitor
Date:6/4/2008

SAN FRANCISCO, June 4 /PRNewswire/ -- Launch of the Pain Clinic Monitor, a new audit of Pain Clinics, was announced today by WWMR, Inc. a leader in pain reporting and analysis. First quarter 2008 results are now available, providing details on 2000 patients, the drugs they are prescribed and why, treatments received in the office, drugs discontinued and why, as well as additional valuable details.

The Monitor is a monthly audit of a balanced selection of 100 Academic and Office-based Pain Clinics, each reporting treatment details for 10 patients, and is the basis for the 27 Pain Condition Profiles provided as part of the deliverables. Companies, products and messages are also captured, as the clinicians report on detailing visits for up to five representatives each month.

Speaking on the occasion, Susan Olsen, President, WWMR, said, "Pain control has become a high priority due to the rise in patient expectations for quality of life. This, together with the increasingly chronic nature of many diseases has expanded the need for ongoing pain control, resulting in growth in the number of Pain Clinics to more than 2000. The Pain Clinic Monitor presents a fresh new focus on point of care pain prescribing, and a significant opportunity to obtain actionable findings for Product Development as well as Marketing and Physician Education activities. The Pain Clinic Monitor is unique -- there is no other comparable product available to companies focusing on the treatment of pain."

WWMR, Inc. is a marketing research and strategic consulting and publishing firm with global capabilities, known for conducting focused and solution-oriented research across all phases of drug development.

In support of its extensive services and growing client base, WWMR, Inc. has an experienced staff of Senior Consultants and Market Research Analysts. WWMR, Inc. also continues to expand its line of EP Publications over the coming year, with 2008 U.S. Neuropathic Pain Report -- this fourth edition will feature two new chapters -- Fibromyalgia and Neuropathic Cancer Pain.

Together with the launch of the new website (http://www.wwmr.com) in May of this year, WWMR, Inc. continues to demonstrate its commitment to providing cost-effective business decision support to its Pharmaceutical, Biotech, medical device and diagnostics clients who want to optimize the revenue potential of their product portfolio through effective business decisions.

WWMR, Inc. designs and executes research which brings clarity, reveals innovative opportunities and provides deeper understanding across all phases of drug development. This enables our clients to:

-- Demonstrate the commercial value of product/partnering opportunities

-- Optimize the revenue potential of their product portfolio

-- Identify and evaluate additional business opportunities

For more information about the Pain Clinic Monitor and other services provided by WWMR, Inc., please contact Michelle Nordstrom, Office and Production Manager at the Corporate Headquarters:

WWMR, Inc.

2929 Campus Drive

Suite 200

San Mateo, CA 94403

Phone: (888) 947-2339

(650) 513-0300

Fax: (650) 312-1570

Web: http://www.WWMR.com

Email: Michelle_Nordstrom@WWMR.com

Companies:

aaiPharma, Merck, Abbott, Mundi Pharma, Adolor, Napp Pharm, Almirall Prodesfarma, NeuroSearch, Altea Therapeutics, Newron Pharmaceuticals, Alza, Nippon Kayaku, Astra Zeneca, Novartis Pharmaceuticals, Avigen, Pain Therapeutics, Boehringer Ingelheim, Pfizer, Bristol-Meyers Squibb, Pharmos, CeNeS Pharmaceuticals, Purdue Pharma, DOV, Reckitt Benckiser/Vernalis, Durect, Rinat Neuroscience/Pfizer, Elan Pharm, Roche, Eli Lilly, Sanofi-Aventis, Endo Pharm, Schwarz, Forest Laboratories, Sosei R&D, Gedeon Richter, Teikoku Seiyaku, GlaxoSmithKline, TheraQuest, Grunenthal, Vernalis, GW Pharmaceuticals, Watson Pharm, Janssen-Cilag, Wyeth Pharmaceuticals Javelin Pharmaceuticals, Xanodyne, Johnson & Johnson, EpiCept, King Pharmaceuticals

Leading Products Detailed:

Avinza, Lyrica, Celebrex, Opana, Cymbalta, Opana ER, Flector Patch, OxyContin, Kadian, Skelaxin Lidoderm


'/>"/>
SOURCE WWMR, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China Kangtai Cactus Biotech Announces Improved Milk Production in Cows From Companys Cactus Cattle Feed
2. BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering
3. Exelixis Announces June 10 Webcast of Presentation at the Goldman Sachs 29th Annual Global Healthcare Conference
4. Angiotech announces completion of Bio-Seal(TM) clinical trial enrolment
5. Cynosure Announces Schedule of Upcoming Investor Conferences
6. Boston Scientific Announces CEO Jim Tobin to Extend Tenure
7. Growing Generations Announces Surrogacy Program for Men with HIV
8. DRCs Metrigraphics Announces Family of Micro-Induction Coils for Implanted and Traditional Medical Applications
9. Ingenuity Systems Announces Multi-Year Agreement With Boehringer Ingelheim
10. American Oriental Bioengineering Announces Proposed Private Offering to Raise $125 Million via Convertible Preferred Stock
11. Spectral announces presentation of data on improving sepsis patient management with EAA(TM) and Toraymyxin(TM) combination
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory ... technical consulting, provides a free webinar on Performing Quality Investigations: Getting ... at 12pm CT at no charge. , Incomplete investigations are still a major ...
(Date:6/22/2016)... Research and Markets has announced the addition of the ... The global biomarkers market has ... The market is expected to grow at a five-year compound annual ... $50.6 billion in 2015 to $96.6 billion in 2020. ... to 2020) are discussed. As well, new products approved in 2013 ...
Breaking Biology Technology:
(Date:5/9/2016)... DUBAI , UAE, May 9, 2016 ... choice when it comes to expanding freedom for high ... Even in today,s globally connected world, there ... online conferencing system could ever duplicate sealing your deal ... are obtaining second passports by taking advantage of citizenship ...
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/19/2016)... 2016 The new GEZE SecuLogic ... web-based "all-in-one" system solution for all door components. It ... the door interface with integration authorization management system, and ... The minimal dimensions of the access control and the ... installations offer considerable freedom of design with regard to ...
Breaking Biology News(10 mins):